Intas Pharmaceuticals Ltd.

Premium

Healthcare

05 January, 2024

Bottomline: ChrysCap, SWFs-backed Intas Pharma facing headwinds

Gujarat-based drugmaker Intas Pharmaceuticals Ltd has had a nearly three-decade-long tryst with private equity investors, having raised capital from ICICI ......

Premium

Healthcare

13 September, 2023

ChrysCapital-backed Intas Pharma weighs $1-bn bid for Biogen's biosimilars biz

Intas Pharmaceuticals Ltd is preparing a bid for Biogen Inc.’s biosimilar business in a transaction that could be valued at ......

Premium

Healthcare

08 June, 2020

Ascent-backed Naari to acquire drug applications portfolio to boost US biz

Ascent Capital-backed Naari Pharma Pvt. Ltd is set to acquire a portfolio of abbreviated new drug applications (ANDAs) from a ......

Premium

Finance

09 April, 2020

How PE and M&A dealmaking turned out in healthcare sector in Jan-March

India’s healthcare sector recorded fewer private equity transactions as well as mergers and acquisitions in the first quarter of 2020 ......

Premium

Healthcare

22 January, 2020

ChrysCapital set to reinvest in another pharmaceutical portfolio firm

Homegrown private equity firm ChrysCapital is in advanced talks to increase its stake in its oldest pharmaceutical portfolio company, which ......

Premium

Healthcare

26 October, 2017

Aurobindo Pharma ends big-ticket bid for Mallinckrodt's generics biz

Drugmaker Aurobindo Pharma Ltd has walked away from the race to purchase the generics business of UK-based Mallinckrodt Plc in ......

Premium

Healthcare

26 May, 2017

Temasek-backed Intas triumphs in trademark battle against rival

The Bombay High Court has dismissed a case against Intas Pharmaceuticals Ltd filed by a rival drugmaker alleging violation of ......

Premium

Healthcare

17 April, 2017

Company watch: PE-backed Intas Pharma enjoying a healthy dose of growth

It was in 1996 that Intas Pharmaceuticals Ltd first attracted a private equity investor. Twenty-one years later, PE firms’ interest ......

Premium

Healthcare

03 June, 2014

Temasek emerges as the frontrunner to buy stake in Intas Pharma from ChrysCap

Singapore’s sovereign fund Temasek Holdings has emerged as the front runner in the race to acquire a little over 10 ......

Premium

Healthcare

30 September, 2013

Intas Pharma may reconsider proposed IPO, could look at PE deal to give ChrysCap part exit

Intas Pharmaceuticals Ltd, which had filed its draft red-herring prospectus (DRHP) with SEBI for a proposed initial public offering (IPO) ......